Role of high dose vitamin C in management of hospitalised COVID-19 patients: A minireview
Authors:
- Deven JunejaDeven Juneja
- Anish GuptaAGAnish Gupta
- Sahil KatariaSKSahil Kataria
- Omender SinghOSOmender Singh
Open Access
- 25 September 2022
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Virology
- Vol. 11 (5) , 300-309
Abstract
Role of high dose vitamin C in management of hospitalised COVID-19 patients: A minireviewKeywords
This publication has 54 references indexed in Scilit:
- Ascorbate-dependent vasopressor synthesis: a rationale for vitamin C administration in severe sepsis and septic shock?Critical Care, 2015
- High Dose Intraveneous Vitamin C and Chikungunya Fever: A Case Report2015
- Phase I safety trial of intravenous ascorbic acid in patients with severe sepsisJournal of Translational Medicine, 2014
- Micronutrients at the Interface Between Inflammation and Infection Ascorbic Acid and Calciferol. Part 1: General Overview with a Focus on Ascorbic AcidInflammation & Allergy - Drug Targets, 2011
- Metabolic origin of hypovitaminosis C in acutely hospitalized patientsNutrition, 2010
- Vitamin C: Intravenous Use by Complementary and Alternative Medicine Practitioners and Adverse EffectsPLOS ONE, 2010
- Hypovitaminosis C in hospitalized patientsEuropean Journal of Internal Medicine, 2003
- Vitamin C deficiency in elderly hospitalized patientsThe American Journal of Medicine, 2001
- Antiviral and Immunomodulatory Activities of Ascorbic Acid1996
- Mechanism of inactivation of bacteriophage MS2 containing single-stranded RNA by ascorbic acid.Journal of Nutritional Science and Vitaminology, 1976